Illumina Announces Management Changes, David Smith Joins Codon, SBRI Taps Hassler for Operations Role | GenomeWeb
NEW YORK (GenomeWeb News) - John Stuelpnagel, Illumina’s senior VP, COO and GM for arrays, will shift to a part-time status in April and will give up his seat on the board of directors, although he will continue to work as an Illumina fellow, the firm said this week.
 
Illumina also said Senior VP and GM of Sequencing John West will resign his position as of Feb. 1, and current senior VP and CFO Christian Henry will become acting manager of sequencing.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.